Nov 9, 2021, 15:50 PM by

Nov 9, 2021, 15:49 PM by

Biosimulation tool to conduct ‘what-if’ scenarios with virtual patients recognized in Software/Services category

Nov 9, 2021, 15:49 PM by

Nov 9, 2021, 15:49 PM by

Nov 9, 2021, 15:48 PM by

Rho, a full-service contract research organization (CRO), is showcasing its clinical development expertise during the 12th Annual CNS Summit, taking place at the Encore Boston Harbor Hotel from November 7-10, 2021. Rho’s Chief Medical Officer, Dr. Jack Modell, along with Dr. John Greist and Dr. Thomas Laughren, will present during a Spotlight Session at the Summit. The 50-minute breakout session, titled, “The Seven Essentials of Clinical Development: How to Avoid Shooting Yourself in the Foot” will showcase the speakers’ combined experience in clinical medicine, academic research, regulatory affairs, and development of drugs and medical applications of information technology.

Nov 9, 2021, 15:48 PM by

Nov 9, 2021, 15:48 PM by

CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company has recently launched 3D-QSAR services for scientists to accelerate the drug development process.

Nov 9, 2021, 15:47 PM by

The UK’s first charity focused on antibiotic resistance, Antibiotic Research UK (ANTRUK), hosted its annual lecture in London on Thursday 21st October to bring together experts in research, health economics and politics.

Nov 9, 2021, 15:47 PM by

MMS Holdings – a data-focused clinical research organization – supported Praxis Bioresearch in the development of a therapeutic for apathy in Alzheimer’s disease. Praxis recently received a $2.9 Million Fast-Track SBIR Grant, which, along with the positive clinical data from the Phase 0 program, means the company’s lead development candidate can now advance to early clinical development.

Nov 9, 2021, 15:47 PM by

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has been shortlisted for three international awards. CluePoints, BioNTech and Pfizer’s Phase I/II/III study of SARS-COV-2 RNA vaccine BNT162b2 (Comirnaty) has been selected as a finalist for the Clinical Advance of the Year - COVID-19 Pandemic Special Recognition Award at the Scrip Awards. The company is also in the running for two Citeline Awards: ´Best Sponsor-facing Technology Initiative´ for their business intelligence platform, BEYOND. As well as ´Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities´, for its work with Pfizer / BioNTech.

Nov 9, 2021, 15:47 PM by

AVIA, the nation’s leading digital transformation partner for healthcare organizations, announced today the expansion of its leadership team to support the substantial growth of the company in 2021

Nov 9, 2021, 15:47 PM by

Purdue University and physIQ, a leader in digital medicine, announced Thursday (Oct. 28) the co-development of a viral detection algorithm for smartwatches. This innovation will be the result of a collaboration between physIQ and university engineers. The algorithm will be commercialized by physIQ, which develops solutions designed to improve health care outcomes by applying artificial intelligence to real-time physiological data from wearable sensors.

Nov 9, 2021, 15:47 PM by

Rho , a full-service contract research organization (CRO) with a proven track record of drug development success, today announced that it will be the Statistical and Clinical Coordinating Center for the COVID-19 Vaccine in Autoimmune Disease Non-Responders study. This clinical trial will assess the antibody response to an extra dose of an authorized or approved COVID-19 vaccine in people with autoimmune diseases who did not respond to an original COVID-19 vaccine regimen. The trial also will investigate whether pausing immunosuppressive therapy for autoimmune diseases improves the antibody response to an extra dose of a COVID-19 vaccine in this population. The Phase 2 trial is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and is being conducted by the NIAID-funded Autoimmunity Centers of Excellence.

Nov 9, 2021, 15:47 PM by

Nov 9, 2021, 15:45 PM by

An extensive offering of liquid stable and ready-to-use combined Total Protein/Albumin clinical reference materials are now available from VERICHEM specifically designed and manufactured for the calibration and calibration verification of the analytes on a large number of clinical testing systems,

Nov 9, 2021, 15:45 PM by

Introducing BeatBox: PreOmics launches its new sample preparation tool for tissues and cells

Nov 9, 2021, 15:44 PM by

The new global Rare Disease center of Emmes expects accelerating growth from US and European biotechs

Nov 9, 2021, 15:44 PM by

The first multisite oncology trial undertaken by the independent sector in the UK has started treating its first patient at the Rutherford Cancer Centre North East.

Nov 9, 2021, 15:44 PM by

Innovative Wisconsin-Based Healthcare Network Deploying Kyruus ProviderMatch® Platform to Modernize How Consumers Find Providers Online

Nov 9, 2021, 15:44 PM by

2bPrecise™ announced its Precision Health™ platform is now available in the Epic App Orchard Gallery.